METHOD & APPARATUS TO PERFORM CRYOTHERAPY
20180028250 ยท 2018-02-01
Inventors
Cpc classification
A61B2018/0293
HUMAN NECESSITIES
A61B2018/0212
HUMAN NECESSITIES
A61H39/06
HUMAN NECESSITIES
A61F2/958
HUMAN NECESSITIES
International classification
A61H39/06
HUMAN NECESSITIES
Abstract
Cryosurgery systems, delivery apparatus and methods that provide for the application of cryogen to a treatment area via a low-profile, low pressure, closed-tipped probe. Cryogen is circulated through the probe, and vented to outside of the body, optionally under vacuum pressure, which contributes to increased cryogen throughput.
Claims
1. A cryosurgical system comprising: a cryogen source; a vacuum source; and a cryogen delivery apparatus configured to (i) connect to the vacuum source and the cryogen source, (ii) deliver cryogen in liquid form from the cryogen source through the apparatus at a low positive pressure to a treatment area, and (iii) remove cryogen in gaseous form from the treatment area through the apparatus at a negative pressure produced by the vacuum source.
2. The system according to claim 1, wherein the cryogen delivery apparatus is a catheter having a closed distal end.
3. The system according to claim 2, wherein the closed distal end has one or more blunt tips to contact a surface of the treatment area.
4. The system according to claim 2, wherein the closed distal end has one or more needle tips to penetrate a surface of the treatment area.
5. The system according to claim 1, wherein the low positive pressure is up to positive 20 psi.
6. The system according to claim 1, wherein the negative pressure is up to negative 15 psi.
7. The system according to claim 1, wherein the cryogen source is nitrogen in liquid form.
8. The system according to claim 2, further comprising a console having on-board controls and a temperature sensor in electrical communication with the controls and coupled to the closed distal end of the catheter in a feedback loop arrangement that allows for control of a rate of cryogen delivered and removed by the system based on temperature measured by the sensor.
9. An apparatus for delivery of cryogen to a treatment area within a body, comprising: a proximal attachment end for connection to a cryogen source; a closed distal end having a head with one or more low profile tips to contact the treatment area; and a shaft comprising a first inlet lumen and a second outlet lumen, the first inlet lumen extending from the proximal end to deliver cryogen in liquid form to the tips under low positive pressure, the second outlet lumen extending from the one or more tips to vent cryogen in gaseous form from the treatment area to atmosphere outside the body.
10. An apparatus according to claim 9, wherein the one or more low profile tips have a blunt face to contact a surface of the treatment area.
11. An apparatus according to claim 9, wherein the one or more low profile tips are sufficiently sharp to penetrate a surface of the treatment area.
12. An apparatus according to claim 9, wherein an outer diameter of the first inlet lumen within the one or more low profile tips is no more than 26 gauge.
13. An apparatus according to claim 9, wherein an outer diameter of the second outlet lumen within the one or more low profile tips is no more than 19 gauge.
14. An apparatus according to claim 9, wherein the cryogen source is nitrogen in liquid form and the low positive pressure is up to positive 30 psi.
15. An apparatus according to claim 9, wherein the second outlet lumen has a connection for a vacuum source and is configured to vent the cryogen in gaseous form with a vacuum pressure up to negative 15 psi.
16. An apparatus according to claim 9, wherein the first inlet lumen is arranged co-axially within the second outlet lumen leaving a channel therebetween in fluid communication with the first inlet lumen that defines a flow path to vent the cryogen in gaseous form from the treatment area.
17. A method to deliver cryotherapy to a treatment area, comprising: positioning a closed distal end of a cryoprobe in contact with the treatment area; delivering nitrogen in liquid form through an inlet lumen of the cryoprobe at a low positive pressure to the closed distal end in contact with the treatment area; and applying a negative pressure to an outlet lumen of the cryoprobe to remove nitrogen in gaseous form from the treatment area.
18. The method according to claim 17, wherein the applying step comprises establishing a connection between the outlet lumen and a vacuum source.
19. The method according to claim 18, where the low positive pressure is up to positive 30 psi and the negative pressure is applied by the vacuum source up to negative 15 psi.
20. The method according to claim 17, further comprising sensing temperature at the closed distal end and controlling the delivery of nitrogen in liquid form and removal of nitrogen in gaseous form based on the sensed temperature.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the present disclosure. The present disclosure, and exemplary embodiments according to the disclosure, are more particularly described in the following description, taken in conjunction with and in reference to the following drawings, in which:
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
DETAILED DESCRIPTION
[0033] Various embodiments according to the present disclosure are described below and with reference to the exemplary configurations of a system and probe, and methods of use thereof, as depicted in the FIGURES.
[0034] Exemplary cryosurgery systems, components and parameters thereof, which may implemented in part or whole with the systems, devices and methods of the present invention, include, but are not limited to, the disclosures in U.S. Pat. Nos. 9,301,796 and 9,144,449, entitled Cryosurgery System; co-pending U.S. patent application Ser. No. 14/012,320, filed Aug. 28, 2013; and co-pending U.S. patent application Ser. No. 14/809,826, filed Jul. 27, 2015. Each of these patents and applications is incorporated herein by reference in its entirety and for all purposes.
[0035] The present invention in its various embodiments is directed to a cryosurgery system having a cryogen delivery apparatus. The cryosurgical system may include a cryogen source configured to provide the cryogen to the cryogen delivery apparatus, a regulation apparatus fluidically coupled to the cryogen source and to the cryogen delivery apparatus, and a controller or console with on-board controls communicatively coupled to the regulation apparatus and configured to control the release of cryogen into the cryogen delivery apparatus. The delivery apparatus may be a catheter, probe or needle configuration that applies a medical-grade liquid nitrogen (or other cryogen) to a treatment area via a small, low pressure, closed end catheter.
[0036] In the following description, use of the terms catheter, probe, or needle alone or together is not to be taken as limiting, but rather is exemplary in nature. The disclosure in its various embodiments of a delivery apparatus is meant to encompass the invention broadly in a delivery apparatus, which may include and take the form of one or more of a catheter, probe, needle or other understood term of art. Also, where used herein, proximal refers to the relative position on a device that is closer to a physician during use, while distal refers to a relative position on the device that is farther from a physician during use.
[0037] A simplified perspective view of an exemplary cryosurgery system in which embodiments of the present invention may be implemented is illustrated in
[0038] The console depicted in
[0039]
[0040] In some cases, system charge pressure is actively controlled by a set of three solenoid valves. A cryogenic solenoid valve connected to the head space is used for rough reduction of tank pressure in cases where tank pressure is significantly above the desired set pressure (>5 psi) or during fill operations when tank pressure must be completely relieved. A set of proportional solenoid valves control the pressure vent and pressure build functions. The proportional solenoid valves are driven by a pulse width modulation (PWM) controller which adjusts its duty cycle based on a control voltage, allowing the valve plunger position to open proportional to the control signal. The control signal is driven by a standard proportional integral derivative (PID) control algorithm executable by a central processor of the system. The PID controller collects data from a precision capacitive pressure sensor and adjusts the valve control signal based on the current pressure deviation with respect to the set point, the current rate of change of pressure, and the pressure history. A PID output control signal determines whether venting or building operations occur. This control scheme advantageously implements precise pressure regulation while allowing software changes to the pressure set point. The PID controller is tuned (inputs P, I, and D) to provide quick response with minimal overshoot or undershoot, while avoiding unstable cycling between vent and build operations.
[0041] A mechanical relief valve 182 on the console tank ensures that the tank pressure stays in a safe pressure range. Constant pressure monitoring and adjustment, allows the set point on the mechanical relief valve to be set at a lower pressure, e.g., 35 psi, allowing for a low tank storage pressure. A redundant burst disk 184 provides protection should the mechanical relief valve fail. For optimal safety, both electronic and mechanical pressure valves may be present to regulate the pressure, providing triple redundancy in the event of failure. In addition, a redundant pressure switch 180 may provide accurate tank pressure readings and is checked during the self-test. In an alternate embodiment, the mechanical relief valve 182 may be set at 60 psi, but still allowing to remain a low pressure storage tank.
[0042] One or more embodiments of the present invention may utilize a manifold assembly including cryogen valve 186, manifold 196, catheter valve 188, defrost valve 190, fixed orifices 191 and 192, and catheter interface 193 to control liquid nitrogen delivered through the catheter. When the cryogen valve 186 is actuated, liquid nitrogen exits the tank through the lance 194 and proceeds through the cryogen valve 186 to manifold 196 where fixed orifice 192 is present to allow cold expanded gas and liquid cryogen to exit the line and cool down the internal cryogen circuit. During this precool, the catheter valve 188 downstream of the manifold remains closed. A data acquisition board collects data from a thermocouple 195 located on the manifold body. In the precool function, the system software monitors data from the thermocouple 195, and opens the cryogen valve 186 to cool the manifold 196 when its temperature is above the desired set-point. Fixed orifice 191 may be provided on catheter interface 193 to allow venting of cold expanded gas to exit the line during cryogen delivery.
[0043] In one embodiment, as represented in
[0044] A defrost function may be useful for thawing the catheter after cryogen delivery. A defrost circuit directs gaseous nitrogen from the top of the tank through a heater 187 and defrost valve 190 to the catheter 128. When the defrost button on the software screen is pressed, the defrost circuit is activated for a prescribed time (e.g., 30 seconds) but may be stopped earlier at the user's discretion. A low voltage (24 VDC) DC defrost heater delivers 6W minimum of warming/defrost performance but minimizes variation due to line voltage and limits maximum gas temperature, as compared to prior art line voltage (120V) AC heaters.
[0045] As liquid nitrogen travels from tank 126 to the proximal end of cryogen delivery catheter 128, the liquid is warmed and starts to boil, resulting in cool gas emerging from the distal end or tip of catheter 128. The amount of boiling in catheter 128 depends on the mass and thermal capacity of catheter 128. Since catheter 128 is of small diameter and mass, the amount of boiling is not great. When the liquid nitrogen undergoes phase change from liquid to gaseous nitrogen, additional pressure is created throughout the length of catheter 128. In an alternate embodiment, the gas boiling inside the catheter may be reduced even greater by the use of insulating materials such as PTFE, FEP, Pebax and others to help reduce its temperature coefficient. The addition of PTFE is especially desirable if done in the inner lumen because its lower coefficient of friction aids in laminar flow of the fluid, thus reducing turbulence and entropy. This reduces gas expansion and allows for good fluid velocity.
[0046] The various embodiments of a catheter in accordance with the present disclosure are designed to transport liquid nitrogen (or other cryogen) from a console to a patient treatment site. According to one embodiment, with reference to
[0047] The delivery catheter may be constructed out of hypotubes of different internal diameters mated to each other to make a proximal shaft and a distal shaft, with the distal shaft containing the smaller ID. The proximal and distal shafts may be joined at a connector. The distal shaft may have a reduced ID to be able to fit through a working channel of a scope or trocar. The hypotubes may be laminated with a polymeric heat shrink which seals the laser cut pattern from the liquid intended to flow inside the catheter.
[0048] The polymer layer may be any suitable flexible polymer that is substantially gas impermeable (for example fluorinated ethylene propylene or urethane), and may be disposed over the hypotube in the form of one or more extrusion layers attached by means of heat shrinking, or by means of dip coating, melt coating or spray coating. The catheter package may contain an RFID tag that the user scans prior to use to prevent reuse and track disposable information. An alternative construction locates the RFID tag on the connector area adjacent to the bayonet, such that a RFID tag may be scanned by the system, such as by RFID reader 306, when the catheter is connected to the system.
[0049] The delivery catheter in other embodiments may be constructed of one or more layers of flexible polyimide, surrounded by a stainless steel braid, which is in turn coated with an outer layer of Pebax. Extrusion of Pebax over the stainless steel braid may allow the Pebax to wick through the pitch of the steel braid, helping to prevent kinking, breaking, or delamination during retroflex of the catheter. The Pebax may also provide a desirable balance between hardness, which is important for smooth sliding of the catheter and general toughness, and softness, which is important for some degree of tackiness which allows the user to feel the movement of the catheter during insertion. The pitch of the stainless steel braid can be configured to be fine enough to afford the required strength, but still allow the Pebax to wick through.
[0050] Referring again to
[0051]
[0052]
[0053] Various configurations in accordance with the present disclosure for the distal end of a catheter, such delivery apparatus 128 of
[0054]
[0055] An alternative embodiment according to the present invention that utilizes a vacuum source is depicted in
[0056]
[0057] The relative inner diameters of the outer jacket and inner jacket are maintained such that a channel is formed between the two that defines an outlet flow path 920 as liquid nitrogen exits the inner jacket 904 at opening 904c and travels along the channel to the proximal end of outer jacket 908. A diffuser 912 at the outlet of outer jacket 908 ensures that any residual liquid nitrogen is converted to gaseous nitrogen before it exits probe head 900. Inner jacket 904 and outer jacket 908 include, respectively, insulation 906, 910 around portions of the exterior of the jackets where an insulating effect is desirable and exposure to the user and patient is not desired. Gaseous nitrogen exits to the atmosphere directly from diffuser 912, as shown, or may follow a path directed by an optional vacuum source before venting, for example, similar to the extension of the outer jacket and pump arrangement depicted in
[0058] The various needle/probe embodiments in accordance with the present invention may be configured as a single needle, such as described with reference to
[0059] In various embodiments according to the present disclosure, the probe head may include a temperature sensor.
[0060] Various shapes, number and configuration of closed-tip needles are contemplated within the scope of the present disclosure. The needle tips may have blunt contact surfaces, such as depicted and described with respect to
[0061] Exemplary dimensions for the inner and outer jackets 804, 808 of catheter head 800 include: Inner jacket: the larger diameter portion 804a may have an ID of 0.104 (2.64 mm) and an OD of 0.112 (2.84 mm); the smaller diameter portion 804c may have an ID of 0.010 (0.26 mm) and an OD of 0.018 (0.46 mm or 26 gauge); Outer jacket: the larger diameter portion 808a may have an ID of 0.140 (3.56 mm) and an OD of 0.150 (3.81 mm); the smaller diameter portion 808b may an ID of 0.027 (0.80 mm) and an OD of 0.042 (1.07 mm or 19 gauge). The overall OD of the catheter head 800 at the larger diameter portion including the insulation 810 may be 0.18 (4.57 mm).
[0062] Exemplary dimensions for the inner and outer jackets 904, 908 of catheter head 900 include: Inner jacket: the larger diameter portion 904a may have an ID of 0.104 (2.64 mm) and an OD of 0.112 (2.84 mm); the smaller diameter portion 904b may have an ID of 0.010 (0.26 mm) and an OD of 0.018 (0.46 mm or 26 gauge); Outer jacket: the larger diameter portion 908a may have an ID of 0.135 (3.43 mm) and an OD of 0.148 (3.76 mm); the smaller diameter portion 908b may an ID of 0.035 (0.89 mm) and an OD of 0.042 (1.07 mm or 19 gauge).
[0063] Exemplary material for the inner and outer jackets include surgical grade stainless steel or nitinol hypotubes that are, for example, laser cut to desired configurations. Ball tip 934 may be surgical grade stainless steel. Exemplary material for insulations 806, 810, 906, 910 include shrink wrap polyimide, FEP, PTFE, and PEBAX, among others. Material 930 may be an epoxy adhesive. Dimensions and materials for the jackets, insulation and needle tips may be varied in accordance with the present disclosure, and choices for an intended purpose may be readily determined by one skilled in the art in order to optimize a particular configuration or treatment protocol.
[0064] Methods according to various embodiments of the present invention involve the use of contact cryotherapy, which when the treatment site is internal to the body, includes visual guidance of a laparoscope or endoscope (in its broadest interpretation, endoscope is intended to include all forms of scopes that are configured for access through a natural opening in the body, as compared to the percutaneous access of a laparoscope, including but not limited to, gastroscope, ENT scope, colonoscope, ureteroscope, cystoscope, hysteroscope, bronchoscope). While described with respect to therapy at sites internal to the body, the systems and devices disclosed are applicable as well to contract cryotherapy external to the body, such as dermatological treatment of lesions, tumors, etc.
[0065] In either of the internal or external approaches, a physician or other user, in accordance with the various embodiments of the invention, attaches the proximal end of a catheter to a source of cryogen, such as by mating bayonet 402 of the catheter connection housing 403 to the catheter interface 318, and liquid nitrogen source 126, of the console of system 100 in
[0066] Feedback loop and software controls may be utilized that meter the cryogen delivery based on feedback that is received from the system, for example, dosing parameters calculated based on the maintenance of a certain level of liquid nitrogen temperatures at the treatment area for predetermined time periods. An example of a suitable cryogen source and console set-up and controls for low pressure delivery of liquid nitrogen is the TruFreeeze system, available from CSA Medical, Inc.; provided, however, catheters configured according to the present disclosure for interface with an alternative source of low pressure cryogen would be suitable as well.
[0067] Once the proximal end of the delivery apparatus is attached to a cryogen source, and system set-up is complete, the apparatus may be inserted into the body of the patient proximate the treatment site. Insertion may be achieved through a trocar independent of the working channel of laparoscope, such as shown in
[0068] Cryogen delivery is started and maintained for the duration of the procedure with flow, and optionally suction, being operated via manual or automatic controls, such as, respectively, foot pedals 110, 111, alone or in conjunction with electronic feedback loop control tied to temperature monitoring. Cryogen, e.g., liquid nitrogen, flows at low pressure (e.g., 14.5 psi) through the catheter shaft into the distal tip of the catheter head. At the transition point, the liquid nitrogen passes into a reduced diameter section of tubing, such as the transition at shoulder 804b from the larger ID (e.g., 2.64 mm) portion 804a of inner jacket 804 to the smaller ID (e.g., 26 gauge, 0.46 mm) needle portion 804c. Upon exiting the smaller diameter tubing, the cryogen impacts upon the contact face of the outer jacket, such as the flow of liquid nitrogen (designated as 816 in
[0069] Embodiments of the methods, devices and system, as described above, and otherwise in accordance with the present invention, result in greater throughput of liquid nitrogen, e.g., more liquid nitrogen at the contact face in a given amount of time, resulting in faster freeze times, particularly when a vacuum source is applied versus conventional closed systems. Faster freeze times are thought to enhance cell death and treatment efficacy since the water in the cells is frozen before the cell dehydrates, expanding within the cells and causing cell death when the ice thaws.
[0070] Liquid nitrogen temperatures (e.g., 77 Kelvin) are able to be achieved with cryoprobes according to the present invention while maintaining low pressure input of liquid nitrogen (such as 20 psi) on the inlet side. The lower inlet pressure allows for lower profile needle dimensions, while still maintaining the throughput of liquid nitrogen necessary to achieve the necessary treatment temperatures.
[0071] While the examples presented above may be focused on treatment of particular anatomy, the systems, methods, and principles illustrated thereby, alone or in a system or kit or as part of a method or procedure, including with other accessories, will be understood by those skilled in the art to be applicable to cryotherapy of other systems and conditions within cavities, lumens, tracts, vessels and organs of the body, in which delivery of cryogen to a site, including the esophagus, peritoneal, abdominal, bronchial or thoracic cavities, vasculature, gastrointestinal or urinary tract, uterus, bladder, lung, liver, stomach, duodenum, small intestine, large intestine, rectum, fallopian tube, etc., is desired.
[0072] The phrase and/or, as used herein should be understood to mean either or both of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Other elements may optionally be present other than the elements specifically identified by the and/or clause, whether related or unrelated to those elements specifically identified unless clearly indicated to the contrary.
[0073] As used in this specification, the term substantially or approximately means plus or minus 10% (e.g., by weight or by volume), and in some embodiments, plus or minus 5%. Reference throughout this specification to one example, an example, one embodiment, or an embodiment means that a particular feature, structure, or characteristic described in connection with the example is included in at least one example of the present technology. Thus, the occurrences of the phrases in one example, in an example, one embodiment, or an embodiment in various places throughout this specification are not necessarily all referring to the same example.
[0074] Certain embodiments of the present invention have been described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention. Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention. In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. As such, the scope of the present disclosure is not to be limited by the preceding illustrative description, but instead is defined by the following claims.